S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
Log in
(Ad)
And Reuters magazine calls this type of trading "the new baby boomer hobby." An anonymous trader -- living at the base of the Smoky Mountains -- just released a free report revealing a step-by-step system to generating an extra $5,000 per month in income thanks to this trading strategy. The report is free until Sunday.

NASDAQ:MBIO - Mustang Bio Stock Price, Forecast & News

$4.33
-0.19 (-4.20 %)
(As of 01/20/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.30
Now: $4.33▼
$4.55
50-Day Range
$3.03
MA: $3.76▼
$4.52
52-Week Range
$2.51
Now: $4.33▼
$10.20
Volume336,627 shs
Average Volume380,160 shs
Market Capitalization$175.62 million
P/E RatioN/A
Dividend YieldN/A
Beta2.29
Mustang Bio, Inc, a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. Read More…

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MBIO
Previous Symbol
CUSIPN/A
CIK1680048
Webhttp://www.mustangbio.com/
Phone781-652-4500

Debt

Debt-to-Equity Ratio0.24
Current Ratio11.82
Quick Ratio11.82

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book Value$1.32 per share
Price / Book3.28

Profitability

EPS (Most Recent Fiscal Year)($1.14)
Net Income$-30,660,000.00
Net MarginsN/A
Return on Equity-84.42%
Return on Assets-62.22%

Miscellaneous

Employees38
Outstanding Shares40,560,000
Market Cap$175.62 million
Next Earnings Date3/16/2020 (Estimated)
OptionableOptionable

Receive MBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for MBIO and its competitors with MarketBeat's FREE daily newsletter.

NASDAQ:MBIO Rates by TradingView

(Ad)


I call it my "Dividend Map", and I'll show you exactly where to find the safest companies that pay the highest yields. (HINT: Texas has 6 of these companies sending huge payouts that average 77%!). I'm willing to send you my Map... but only if you

Mustang Bio (NASDAQ:MBIO) Frequently Asked Questions

What is Mustang Bio's stock symbol?

Mustang Bio trades on the NASDAQ under the ticker symbol "MBIO."

How were Mustang Bio's earnings last quarter?

Mustang Bio Inc (NASDAQ:MBIO) released its earnings results on Tuesday, November, 12th. The company reported ($0.25) earnings per share for the quarter, beating analysts' consensus estimates of ($0.26) by $0.01. View Mustang Bio's Earnings History.

When is Mustang Bio's next earnings date?

Mustang Bio is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Mustang Bio.

What price target have analysts set for MBIO?

3 brokerages have issued 12-month price objectives for Mustang Bio's stock. Their forecasts range from $7.00 to $18.00. On average, they anticipate Mustang Bio's stock price to reach $10.67 in the next year. This suggests a possible upside of 146.3% from the stock's current price. View Analyst Price Targets for Mustang Bio.

What is the consensus analysts' recommendation for Mustang Bio?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mustang Bio in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Mustang Bio.

Has Mustang Bio been receiving favorable news coverage?

Headlines about MBIO stock have trended extremely negative on Monday, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Mustang Bio earned a media sentiment score of -5.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Mustang Bio.

Are investors shorting Mustang Bio?

Mustang Bio saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 610,700 shares, an increase of 9.1% from the December 15th total of 560,000 shares. Based on an average daily volume of 337,000 shares, the days-to-cover ratio is presently 1.8 days. Approximately 2.2% of the shares of the stock are sold short. View Mustang Bio's Current Options Chain.

Who are some of Mustang Bio's key competitors?

What other stocks do shareholders of Mustang Bio own?

Who are Mustang Bio's key executives?

Mustang Bio's management team includes the folowing people:
  • Mr. Michael S. Weiss, Exec. Chairman (Age 53)
  • Dr. Manuel Litchman, Pres, CEO & Director (Age 65)
  • Mr. David Jay Horin CPA, Interim Chief Financial Officer (Age 51)
  • Mr. Brian K. Achenbach, VP of Fin. & Corp. Controller (Age 54)
  • Dr. Knut Niss, Chief Technology Officer

Who are Mustang Bio's major shareholders?

Mustang Bio's stock is owned by a number of of institutional and retail investors. Top institutional investors include FNY Investment Advisers LLC (0.32%). View Institutional Ownership Trends for Mustang Bio.

Which major investors are buying Mustang Bio stock?

MBIO stock was purchased by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC. View Insider Buying and Selling for Mustang Bio.

How do I buy shares of Mustang Bio?

Shares of MBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Mustang Bio's stock price today?

One share of MBIO stock can currently be purchased for approximately $4.33.

How big of a company is Mustang Bio?

Mustang Bio has a market capitalization of $175.62 million. The company earns $-30,660,000.00 in net income (profit) each year or ($1.14) on an earnings per share basis. Mustang Bio employs 38 workers across the globe.View Additional Information About Mustang Bio.

What is Mustang Bio's official website?

The official website for Mustang Bio is http://www.mustangbio.com/.

How can I contact Mustang Bio?

Mustang Bio's mailing address is 2 GANSEVOORT STREET 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 781-652-4500 or via email at [email protected]


MarketBeat Community Rating for Mustang Bio (NASDAQ MBIO)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  130 (Vote Outperform)
Underperform Votes:  145 (Vote Underperform)
Total Votes:  275
MarketBeat's community ratings are surveys of what our community members think about Mustang Bio and other stocks. Vote "Outperform" if you believe MBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Featured Article: Trading Penny Stocks
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel